|
|
40
|
|
|
B151C
|
|
|
XARELTO 2.5MG TAB (BSP/AHI) RIVAROXABAN
|
|
|
RIVAROXABAN
|
|
|
XARELTO
|
|
|
28'S
|
|
|
C
|
|
|
84.81
|
|
|
3.03
|
|
|
2.5MG
|
|
|
TABLET
|
|
|
0
|
|
|
TAB
|
|
|
BSP
|
|
|
BAYER SCHERING PHARMA AG.
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No
|
|
|
20120412
|
|
|
DIRECT THROMBIN INHIBITORS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|